Anna M Ehlers1,2, Henny G Otten1, Eva Wierzba3, Ulrike Flügge3, Thuy-My Le1,2, André C Knulst1,2, Waltraud Suer3. 1. Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands. 2. Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands. 3. Euroimmun AG, Lübeck, Germany.
Abstract
BACKGROUND: Although hen's egg allergy is more prevalent in children, up to 0.6% of adults from different European countries suffer from a persistent or newly onset hen's egg allergy, making accurate diagnosis in adults necessary. However, sensitization to hen's egg extracts, components and linear epitopes is solely studied in children. METHODS: Hen's egg allergic (n = 16) and tolerant (n = 19) adults were selected by sensitization towards recombinant components rGal d 1 and/or 3. Sensitization profiles towards egg white and yolk extract and the native components Gal d 1, 2, 3 and 4 were respectively evaluated with the ImmunoCAP or the EUROLINE system. Characterization of linear epitopes was performed with a peptide microarray containing 15mer peptides representing the entire sequence of mature Gal d 1 and 3. RESULTS: Overall, sIgE titres against hen's egg extracts and single components overlapped largely between allergic and tolerant adults. Although the median sIgE/sIgG4 ratio to Gal d 1 was increased in allergic adults, the range was comparable between both groups. Clinically relevant sensitization to Gal d 1 was confirmed by sIgE-binding to the linear epitopes aa30-41, aa39-50 or aa84-95 in 6/13 allergic adults, mainly suffering from objective symptoms. In comparison, these epitopes were recognized by 1/15 tolerant patient. Only a few linear epitopes were detected for Gal d 3, suggesting a greater importance of conformational epitopes for the recognition of Gal d 3. CONCLUSION AND CLINICAL RELEVANCE: Specific IgE-binding to linear epitopes of Gal d 1 is highly specific in identifying hen's egg allergic adults with objective symptoms.
BACKGROUND: Although hen's egg allergy is more prevalent in children, up to 0.6% of adults from different European countries suffer from a persistent or newly onset hen's egg allergy, making accurate diagnosis in adults necessary. However, sensitization to hen's egg extracts, components and linear epitopes is solely studied in children. METHODS: Hen's egg allergic (n = 16) and tolerant (n = 19) adults were selected by sensitization towards recombinant components rGal d 1 and/or 3. Sensitization profiles towards egg white and yolk extract and the native components Gal d 1, 2, 3 and 4 were respectively evaluated with the ImmunoCAP or the EUROLINE system. Characterization of linear epitopes was performed with a peptide microarray containing 15mer peptides representing the entire sequence of mature Gal d 1 and 3. RESULTS: Overall, sIgE titres against hen's egg extracts and single components overlapped largely between allergic and tolerant adults. Although the median sIgE/sIgG4 ratio to Gal d 1 was increased in allergic adults, the range was comparable between both groups. Clinically relevant sensitization to Gal d 1 was confirmed by sIgE-binding to the linear epitopes aa30-41, aa39-50 or aa84-95 in 6/13 allergic adults, mainly suffering from objective symptoms. In comparison, these epitopes were recognized by 1/15 tolerant patient. Only a few linear epitopes were detected for Gal d 3, suggesting a greater importance of conformational epitopes for the recognition of Gal d 3. CONCLUSION AND CLINICAL RELEVANCE: Specific IgE-binding to linear epitopes of Gal d 1 is highly specific in identifying hen's egg allergic adults with objective symptoms.
Authors: Toral A Kamdar; Sarah Peterson; Claudia H Lau; Carol A Saltoun; Ruchi S Gupta; Paul J Bryce Journal: J Allergy Clin Immunol Pract Date: 2014-08-29
Authors: Timothy J Looney; Ji-Yeun Lee; Krishna M Roskin; Ramona A Hoh; Jasmine King; Jacob Glanville; Yi Liu; Tho D Pham; Cornelia L Dekker; Mark M Davis; Scott D Boyd Journal: J Allergy Clin Immunol Date: 2015-08-22 Impact factor: 10.793
Authors: T Zuberbier; G Edenharter; M Worm; I Ehlers; S Reimann; T Hantke; C C Roehr; K E Bergmann; B Niggemann Journal: Allergy Date: 2004-03 Impact factor: 13.146
Authors: Sarah A Lyons; Peter G J Burney; Barbara K Ballmer-Weber; Montserrat Fernandez-Rivas; Laura Barreales; Michael Clausen; Ruta Dubakiene; Cristina Fernandez-Perez; Philipp Fritsche; Monika Jedrzejczak-Czechowicz; Marek L Kowalski; Tanya Kralimarkova; Ischa Kummeling; Tihomir B Mustakov; Ans F M Lebens; Harmieke van Os-Medendorp; Nikolaos G Papadopoulos; Todor A Popov; Alexandros Sakellariou; Paco M J Welsing; James Potts; E N Clare Mills; Ronald van Ree; André C Knulst; Thuy-My Le Journal: J Allergy Clin Immunol Pract Date: 2019-03-19
Authors: Anna M Ehlers; Henny G Otten; Eva Wierzba; Ulrike Flügge; Thuy-My Le; André C Knulst; Waltraud Suer Journal: Clin Exp Allergy Date: 2020-09-24 Impact factor: 5.018
Authors: K Soares-Weiser; Y Takwoingi; S S Panesar; A Muraro; T Werfel; K Hoffmann-Sommergruber; G Roberts; S Halken; L Poulsen; R van Ree; B J Vlieg-Boerstra; A Sheikh Journal: Allergy Date: 2013-12-14 Impact factor: 13.146
Authors: Ruchi S Gupta; Christopher M Warren; Bridget M Smith; Jialing Jiang; Jesse A Blumenstock; Matthew M Davis; Robert P Schleimer; Kari C Nadeau Journal: JAMA Netw Open Date: 2019-01-04
Authors: Anna M Ehlers; Henny G Otten; Eva Wierzba; Ulrike Flügge; Thuy-My Le; André C Knulst; Waltraud Suer Journal: Clin Exp Allergy Date: 2020-09-24 Impact factor: 5.018